Login / Signup

Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study.

Jan KassubekStewart A FactorErnest BalaguerJohannes SchwarzKallol Ray ChaudhuriStuart H IsaacsonStacy WuCarmen Denecke MuhrJaime Kulisevsky
Published in: Journal of neurology (2024)
SL-APO was generally well tolerated and efficacious over the long term as an on-demand treatment for OFF episodes in patients with PD.
Keyphrases
  • open label
  • clinical trial
  • phase ii
  • phase ii study
  • study protocol
  • squamous cell carcinoma
  • combination therapy
  • smoking cessation